Onderzoeker
Christel Fontaine
- Trefwoorden:Geneeskunde
- Disciplines:Kankertherapie
Affiliaties
- Medische Oncologie (Departement)
Lid
Vanaf1 jun 2010 → Heden - Laboratorium Moleculaire Oncologie (Onderzoeksgroep)
Lid
Vanaf1 jan 2010 → Heden - Observerende Klinische wetenschappen (Departement)
Lid
Vanaf5 jan 2021 → Heden - Observerende Klinische wetenschappen (Departement)
Lid
Vanaf1 mei 2012 → 20 okt 2022
Publicaties
21 - 30 van 32
- The clinical characteristics of breast cancers with a familial risk in which no BRCA1/2 mutations were found are sometimes suggestive for a genetic etiology(2019)
Auteurs: Sofie Joris, Rajendra Bahadur Shahi, Sylvia De Brakeleer, Christel Fontaine, Maryse Bonduelle, Pauwels Ingrid, Erik Teugels, Jacques De Grève
- Retrospective comparison of two consecutive cohorts of adjuvant chemotherapy regimens of cyclophosphamide with either docetaxel or paclitaxel in older patients with early breast cancer.(2019)
Auteurs: Sofie Joris, Christel Fontaine, Lore Decoster, Leen Vanacker, Denis Schallier, Jacques De Grève
Pagina's: 663-666 - Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families(2019)
Auteurs: Rajendra Bahadur Shahi, Sylvia De Brakeleer, Ben Caljon, Ingrid Pauwels, Maryse Bonduelle, Sofie Joris, Christel Fontaine, Marian Vanhoeij, Sonia Van Dooren, Erik Teugels, et al.
- Docetaxel/cyclophosphamide chemotherapy in older patients with breast cancer(2018)
Auteurs: Lore Decoster, Christel Fontaine, Leen Vanacker, Denis Schallier, Jacques De Grève
Pagina's: 695-697 - Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy(2016)
Auteurs: Jean-Pascal Machiels, Aline Van Maanen, Jean-Marie Vandenbulcke, Bertrand Filleul, Emmanuel Seront, Stéphanie Henry, Lionel D'hondt, Christophe Lonchay, Stéphane Holbrechts, Petra Boegner, et al.
Pagina's: 1416-e17 - Mild Lung Restriction in Breast Cancer Patients After Hypofractionated and Conventional Radiation Therapy(2016)
Auteurs: Sylvia Verbanck, Shane Hanon, Daniel Schuermans, Hilde Van Parijs, Vincent Vinh-Hung, Geertje Miedema, Dirk Verellen, Guy Storme, Christel Fontaine, Jan Lamote, et al.
Pagina's: 937-945 - Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma(2016)
Auteurs: M Keyaerts, Catarina Xavier, Johannes Heemskerk, Nick Devoogdt, Hendrik Everaert, Chloé Ackaert, Marian Vanhoeij, Francois P Duhoux, Thierry Gevaert, Pascal Simon, et al.
Pagina's: 27-33 - Diagnostic and prognostic correlates of preoperative FDG PET for breast cancer(2012)
Auteurs: Vincent Vinh-Hung, Hendrik Everaert, Jan Lamote, Maria Voordeckers, Hilde Van Parijs, Marian Vanhoeij, Guy Verfaillie, Christel Fontaine, H Vees, O. Ratib, et al.
Pagina's: 1618-1627 - Savene® (dexrazoxane) use in clinical practice(2012)
Auteurs: Christel Fontaine, L. Noens, P. Pierre, Jacques De Grève
Pagina's: 1109-1112 - Evaluation of a comprehensive rehabilitation program for post-treatment patients with cancer.(2011)
Auteurs: Sophie Hanssens, Rik Luyten, Chris Watthy, Christel Fontaine, Lore Decoster, Catherine Baillon, Fabienne Trullemans, Aisha Cortoos, Jacques De Grève
Pagina's: 418-424